Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,749 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06992778Recruiting
Remote hearing aid fine-tuning for Danish adults
This trial tests whether fine-tuning your hearing aids remotely, using your smartphone, works as well as in-person visits. It might be a good fit if you're comfortable using a smartphone and have mild to moderate hearing loss without complicating ear conditions.
KøgeAges 18 years+ - NCT04935164Recruiting
Study of gender dysphoria versus a control group
This study compares people with gender dysphoria to people without it. It looks at differences in symptoms or outcomes and may help researchers better understand how gender dysphoria affects mental well-being.
PoitiersAges 18–60 - NCT06977724RecruitingPhase 1
Testing a new drug for lupus, sjogren's, and rheumatoid arthritis
This study tests an experimental medicine given by IV infusion to see if it is safe and helps reduce symptoms of lupus, sjogren's disease, or rheumatoid arthritis. It is an early-phase trial, so the main goals are checking side effects and how the drug behaves in the body, but it will also look at how well it works.
Avon Park, FloridaAges 18–75 - NCT06976268RecruitingPhase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Birmingham, AlabamaAges 40–80 - NCT06973187RecruitingPhase 3
Comparing two drugs for CLL or SLL after prior treatment
This trial tests a new drug (BGB-16673) against another drug (pirtobrutinib) for people with CLL or SLL that hasn't responded to or has come back after a prior BTK inhibitor treatment. The goal is to see which drug is more effective and safe.
Birmingham, AlabamaAges 18 years+ - NCT06977737RecruitingPhase 1/Phase 2
Study of ATTR-01 for certain solid tumors
This trial tests a new treatment called ATTR-01 for people with certain types of solid tumors that have a specific protein (αvβ6 integrin) in high amounts. It is for those who have already tried standard treatments and need new options.
BarcelonaAges 18 years+ - NCT06978725RecruitingPhase 2/Phase 3
Brepocitinib for skin sarcoidosis
This study tests an oral drug called brepocitinib to see if it can help people with skin sarcoidosis and reduce skin symptoms. It aims to find a better treatment option for this condition.
San Francisco, CaliforniaAges 18 years+ - NCT06980480RecruitingPhase 3
Gammagard to prevent infections in multiple myeloma
This study tests if adding Gammagard (a type of antibody therapy) to your multiple myeloma treatment with Tecvayli can help prevent serious infections. You may qualify if you recently started Tecvayli and are still responding to it.
Mobile, AlabamaAges 18 years+ - NCT06979674RecruitingPhase 1
ESG406 for advanced solid tumors
This trial tests a new drug called ESG406 in people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and helps shrink tumors.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06975787RecruitingPhase 1
A New Bispecific Antibody for Lupus Nephritis
This trial is testing a new type of medicine called a 'bispecific antibody' for people whose lupus nephritis has not responded to standard treatments or keeps coming back. The goal is to find a safe dose that might better control the kidney inflammation.
San Francisco, CaliforniaAges 18–60 - NCT06980428RecruitingPhase 1
Safety study of AZD4954 in people with or without high Lp(a)
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
Glendale, CaliforniaAges 18–70 - NCT06974370RecruitingPhase 2
Avoiding brain radiation when chemo or other drugs work
This trial tests whether some people with brain metastases from solid tumors can safely skip radiation if their cancer drugs (like targeted therapy, immunotherapy, or certain chemotherapies) shrink the brain tumors. You will get MRI scans to see if the drugs are working.
Burlington, VermontAges 18 years+ - NCT06976528Recruiting
Relationship conflict and heavy drinking in young couples
This study looks at how romantic relationship conflicts and stress relate to heavy drinking in young adults. It involves a lab visit where you may be given alcohol and answer questions about your relationship and drinking habits.
New York, New YorkAges 21–29 - NCT06981169Recruiting
Using inflammation tests to diagnose asthma in kids and adults
This trial uses a simple inflammation test (inflammometry) to help diagnose asthma more accurately in people aged 6 and older who have been sent by their primary care doctor for standard breathing tests. It aims to improve the diagnosis process and reduce delays.
Montreal, QuebecAges 6 years+ - NCT06982066Recruiting
Helping Young Cancer Patients Talk with Their Care Team
This study works with teens and young adults (ages 15–25) who have cancer and are currently in treatment. It tests a way to help you talk better with your doctors and nurses about your care, so they can understand your needs and preferences more clearly.
Hartford, ConnecticutAges 15–25 - NCT06979843Recruiting
Support program for teens and young adults with new cancer diagnosis
This study tests a support model called Team Young, designed to help adolescents and young adults (ages 16-30) who have just been diagnosed with cancer. The goal is to provide emotional and practical support during this challenging time.
GothenburgAges 16 years+ - NCT06978166Recruiting
Digital therapy for chronic pain and mood
This study tests a smartphone app that gives you personalized tips and exercises to help manage chronic pain along with depression or anxiety. It is designed for adults ages 45 and older and aims to see if these digital check-ins can improve how you feel day to day.
St Louis, MissouriAges 45 years+ - NCT06975657Recruiting
Reentry well-being skills study for former inmates
This study tests a program to help people recently released from jail or prison build skills to cope and thrive. It involves group sessions and may help you feel more confident about reentering the community.
Madison, WisconsinAges 18 years+ - NCT04246944Recruiting
Induced membrane bone repair study in critical defects
This study looks at how a specific bone-repair technique (called induced membrane reconstruction) works in people with large “critical-sized” bone defects. It may help doctors understand the results and properties of this method in both children and adults.
AmiensAges 9 months–60 years - NCT06951620Recruiting
Fitness program for older adults after heart attack or stent
This trial tests whether a personalized exercise program can improve aerobic fitness in older adults who have recently had a heart attack or a stent procedure. If you are 65 or older and able to walk, you may be able to join.
South Burlington, VermontAges 65 years+ - NCT06963827RecruitingPhase 3
Study of mezagitamab for IgA nephropathy
This trial tests a new drug called mezagitamab for adults with IgA nephropathy, a kidney condition. The study aims to see if this drug can help reduce protein in the urine and preserve kidney function. You may be eligible if your kidney function is above a certain level and your urine protein is high enough.
Birmingham, AlabamaAges 18 years+ - NCT06963034RecruitingPhase 3
Study of a new medicine for adults with schizophrenia
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
Bryant, ArkansasAges 18–65 - NCT06962800RecruitingPhase 3
Study of felzartamab for adults with primary membranous nephropathy
This study tests whether felzartamab, given as an infusion, can help treat primary membranous nephropathy (a kidney disease causing protein in the urine and swelling). It may reduce protein loss and improve kidney function compared to standard care alone.
Huntsville, AlabamaAges 18–80 - NCT06965374Recruiting
Study of a new Parkinson's injection and quality of life
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
Troina, EnnaAges 18 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,749 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.